FULC
Price
$7.25
Change
+$0.14 (+1.97%)
Updated
Jun 6 closing price
Capitalization
383.52M
59 days until earnings call
OMER
Price
$3.77
Change
+$0.47 (+14.24%)
Updated
Jun 6 closing price
Capitalization
193.36M
59 days until earnings call
Interact to see
Advertisement

FULC vs OMER

Header iconFULC vs OMER Comparison
Open Charts FULC vs OMERBanner chart's image
Fulcrum Therapeutics
Price$7.25
Change+$0.14 (+1.97%)
Volume$388.35K
Capitalization383.52M
Omeros
Price$3.77
Change+$0.47 (+14.24%)
Volume$1.04M
Capitalization193.36M
FULC vs OMER Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. OMER commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Buy and OMER is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (FULC: $6.90 vs. OMER: $3.14)
Brand notoriety: FULC and OMER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 178% vs. OMER: 103%
Market capitalization -- FULC: $383.52M vs. OMER: $193.36M
FULC [@Biotechnology] is valued at $383.52M. OMER’s [@Biotechnology] market capitalization is $193.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileOMER’s FA Score has 1 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • OMER’s FA Score: 1 green, 4 red.
According to our system of comparison, both FULC and OMER are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 3 TA indicator(s) are bullish while OMER’s TA Score has 4 bullish TA indicator(s).

  • FULC’s TA Score: 3 bullish, 5 bearish.
  • OMER’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, OMER is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а +10.40% price change this week, while OMER (@Biotechnology) price change was +0.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

OMER is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($384M) has a higher market cap than OMER($193M). FULC YTD gains are higher at: 46.809 vs. OMER (-68.219). FULC has higher annual earnings (EBITDA): -18.24M vs. OMER (-155.96M). FULC has more cash in the bank: 241M vs. OMER (123M). FULC has less debt than OMER: FULC (8.63M) vs OMER (209M). FULC has higher revenues than OMER: FULC (80M) vs OMER (0).
FULCOMERFULC / OMER
Capitalization384M193M199%
EBITDA-18.24M-155.96M12%
Gain YTD46.809-68.219-69%
P/E RatioN/AN/A-
Revenue80M0-
Total Cash241M123M196%
Total Debt8.63M209M4%
FUNDAMENTALS RATINGS
FULC vs OMER: Fundamental Ratings
FULC
OMER
OUTLOOK RATING
1..100
252
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9211
PRICE GROWTH RATING
1..100
3597
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (27) in the null industry is in the same range as OMER (46) in the Biotechnology industry. This means that FULC’s stock grew similarly to OMER’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as OMER (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to OMER’s over the last 12 months.

OMER's SMR Rating (11) in the Biotechnology industry is significantly better than the same rating for FULC (92) in the null industry. This means that OMER’s stock grew significantly faster than FULC’s over the last 12 months.

FULC's Price Growth Rating (35) in the null industry is somewhat better than the same rating for OMER (97) in the Biotechnology industry. This means that FULC’s stock grew somewhat faster than OMER’s over the last 12 months.

FULC's P/E Growth Rating (100) in the null industry is in the same range as OMER (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to OMER’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULCOMER
RSI
ODDS (%)
Bearish Trend 12 days ago
77%
Bullish Trend 12 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
85%
Bullish Trend 12 days ago
80%
Momentum
ODDS (%)
N/A
Bearish Trend 12 days ago
89%
MACD
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
86%
Bearish Trend 12 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
87%
Bearish Trend 12 days ago
89%
Advances
ODDS (%)
Bullish Trend 21 days ago
86%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
72%
Aroon
ODDS (%)
Bullish Trend 12 days ago
87%
Bearish Trend 12 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

OMER and

Correlation & Price change

A.I.dvisor indicates that over the last year, OMER has been loosely correlated with INM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMER
1D Price
Change %
OMER100%
-0.95%
INM - OMER
46%
Loosely correlated
-5.40%
MDXG - OMER
34%
Loosely correlated
-3.84%
TGTX - OMER
32%
Poorly correlated
-0.28%
FULC - OMER
32%
Poorly correlated
+8.66%
LXRX - OMER
31%
Poorly correlated
+1.36%
More